about
Folate decorated dual drug loaded nanoparticle: role of curcumin in enhancing therapeutic potential of nutlin-3a by reversing multidrug resistanceAchieving optimal cancer outcomes in East Africa through multidisciplinary partnership: a case study of the Kenyan National Retinoblastoma Strategy groupDetection of leukocoria using a soft fusion of expert classifiers under non-clinical settingsDevelopment of retinoblastoma programs in Central America.Clinical presentation of retinoblastoma in Alexandria: A step toward earlier diagnosisTwenty-Year Collaboration Between North American and South American Retinoblastoma Programs.Integrating stages of change models to cast new vision on interventions to improve global retinoblastoma and childhood cancer outcomesRetinoblastoma. Fifty years of progress. The LXXI Edward Jackson Memorial Lecture.Colorimetric and longitudinal analysis of leukocoria in recreational photographs of children with retinoblastoma.Targeting the p53 pathway in retinoblastoma with subconjunctival Nutlin-3a.Consequences of delayed diagnosis in treatment of retinoblastomaEpidemiology and Rb1 gene of retinoblastoma.Lentivirus-Mediated Knockdown of Astrocyte Elevated Gene-1 Inhibits Growth and Induces Apoptosis through MAPK Pathways in Human Retinoblastoma CellsRetinoblastoma frontiers with intravenous, intra-arterial, periocular, and intravitreal chemotherapy.Incidence and survival of retinoblastoma in Taiwan: a nationwide population-based study 1998-2011"Retinoblastoma survival disparity": The expanding horizon in developing countries.Extraocular retinoblastoma in Indian children: clinical, imaging and histopathological features.Strategies to manage retinoblastoma in developing countries.Retinoblastoma: lessons and challenges from developing countries. Ellsworth Lecture 2011.Comparison of the diagnostic value of MR imaging and ophthalmoscopy for the staging of retinoblastoma.Management of retinoblastoma: opportunities and challenges.Long non-coding RNA HOTAIR regulates proliferation and invasion via activating Notch signalling pathway in retinoblastoma.A change roadmap towards research paradigm in low-resource countries: retinoblastoma model in Egypt.Lessons from Retinoblastoma: Implications for Cancer, Development, Evolution, and Regenerative Medicine.Causes, outcome and prevention of abandonment in retinoblastoma in India.Toxicogenomics of nanoparticulate delivery of etoposide: potential impact on nanotechnology in retinoblastoma therapy.Cotylenin A inhibits cell proliferation and induces apoptosis and PAX6 mRNA transcripts in retinoblastoma cell lines.Evaluation of cytotoxicity and mechanism of apoptosis of doxorubicin using folate-decorated chitosan nanoparticles for targeted delivery to retinoblastomaPrediagnostic Intervals in Retinoblastoma: Experience at an Oncology Center in Brazil.Childhood cancer and developmental biology a crucial partnership.Childhood cancer and pediatric oncologic care in Brazil: access and equity.Clinical presentation and outcome of retinoblastoma among children treated at the National Cancer Institute (NCI) in Gezira, Sudan: a single Institution experience.Favorable outcome of alternate systemic and intra-arterial chemotherapy for retinoblastoma.The basics of retinoblastoma: back to school.Enucleation Refusal for Retinoblastoma: A Global Study.HSV‑TK/GCV can induce cytotoxicity of retinoblastoma cells through autophagy inhibition by activating MAPK/ERK.SIOP-PODC recommendations for graduated-intensity treatment of retinoblastoma in developing countries
P2860
Q28481616-9392D4EB-9B42-4259-99BE-EA0267FBF8C7Q30384094-58EA175F-D52D-4E5B-A025-7887A5B39AA3Q30587142-7FA4D0D3-88F2-4F2E-8BCD-FBEAC7A9B932Q33575887-E25B1B95-49A2-4485-8B2C-F2C643488328Q33702677-CB49AAC8-E27F-4B73-9457-FBCFC565A245Q33859636-27A57BCD-48CE-407F-AD42-320E57D3538BQ34196347-4271B719-A70C-450F-9115-B12C1F99713FQ34603733-E6877490-829F-4832-980D-88ADD0AECAC5Q35034754-A6FF8203-4E8C-4368-B132-AB94878CBBAEQ35050530-0C4C86FD-D3DC-4912-A22A-E46E869B4C04Q35118530-033DB6BA-38BE-4A64-9E02-FAD8C013F7C3Q35923816-D44EFF05-970B-4BCC-A6E0-FF8CAD4334C2Q36598750-233FE348-CBC2-4472-89A0-B4ECA679DFB0Q36615019-2F2CD785-A4BD-43A6-B37D-FE81E0CB2D53Q36968693-A3F07BC7-8D0B-40A3-994C-3718913361F2Q37060541-3B7E3EFC-1F95-4910-9F66-B509795612E6Q37126865-1CBE6589-F30E-4476-9F57-5D4CF9170B1AQ37827826-C2432F63-E8E4-4275-A5C2-A07F7A6F5AB0Q37902647-9749B5A1-ADDA-43A4-BC27-B192D63D01D2Q38060555-29490459-7831-48C4-B5CA-7D71EC21339AQ38372956-3E3E67B9-2B01-4EF8-8F78-6798F4B0D33AQ38726303-B09C2321-C7B8-40E8-97FD-3A793A3A43EDQ38868310-21877DC0-1BEE-4117-BC0A-0BB15BBF4C38Q38938719-8701DAAF-7EB7-4AC2-9683-9C981836EB3BQ39201889-D0C984BA-E348-4E24-9B04-0366C99A9512Q39614066-092ABE9A-7F32-4E7B-BC4C-026C05A20DC3Q39688506-F5F6DAA4-F648-4EF9-A7F6-F7F67CAB64DEQ39757343-AB84A7CB-6F00-459B-8918-7E5E5B847AE1Q41443027-4A3A2A22-2939-4913-97E8-7EC9F68CE294Q42917104-266EA099-16F2-42B7-B7D7-6E9C12DBE7CCQ43632953-C28B354C-3529-4437-BD6F-D6E0D1DE2058Q44843471-724C7419-DA55-448D-9C6F-1F43ECE743DFQ48861825-82F7B946-E0A6-4784-B29E-B872FBDE3C18Q50992587-C8A89448-8D12-4935-AC2D-31EE3C0E766DQ51807476-E644C567-9D7A-4777-8CBD-836F9E4CD1C0Q54977772-6908DC7A-65D3-4C4B-9CA4-0E7EC9F5EE33Q59209159-855E7E90-8BB0-49BB-AA1E-BBA00D221DB2
P2860
description
2008 nî lūn-bûn
@nan
2008 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
name
Retinoblastoma: one world, one vision
@ast
Retinoblastoma: one world, one vision
@en
type
label
Retinoblastoma: one world, one vision
@ast
Retinoblastoma: one world, one vision
@en
prefLabel
Retinoblastoma: one world, one vision
@ast
Retinoblastoma: one world, one vision
@en
P2093
P2860
P356
P1433
P1476
Retinoblastoma: one world, one vision
@en
P2093
A Linn Murphree
Barrett G Haik
Carlos Leal-Leal
Carlos Rodriguez-Galindo
Célia Antoneli
Eugene M Helveston
Guillermo Chantada
Ibrahim Qaddoumi
Javier R Kane
Joan O'Brien
P2860
P304
P356
10.1542/PEDS.2008-0518
P407
P577
2008-09-01T00:00:00Z